Christopher D. Maggiore - 02 Oct 2025 Form 4 Insider Report for Zivo Bioscience, Inc. (ZIVO)

Reporting relationship: Director, 10%+ Owner
Issuer ticker: ZIVO
Reported as of: 02 Oct 2025
Net transaction value: +$10,965
SEC form: 4
Accepted by SEC: 06 Oct 2025, 20:30:19 UTC
Prior SEC filing: 09 Apr 2025
Next SEC filing: 09 Oct 2025
Source filing: View source filing
Reporting owner signature: /s/ Christopher D. Maggiore

Key filing fact

Christopher D. Maggiore filed Form 4 for Zivo Bioscience, Inc. (ZIVO) on 06 Oct 2025.

Key facts

This page summarizes Christopher D. Maggiore's Form 4 filing for Zivo Bioscience, Inc. (ZIVO).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 06 Oct 2025, 20:30.

Change

Previous filing in this sequence was filed on 09 Apr 2025.
Current net transaction value: +$10,965.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001436075 Primary reporting owner

Maggiore Christopher D.

Relationship: Director, 10%+ Owner
Address: 2125 BUTTERFIELD ROAD, SUITE 100, TROY
Signature: /s/ Christopher D. Maggiore
Signature date: 06 Oct 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ZIVO transaction Derivative

Nonstatutory Stock Options to buy Common Stock

Award

Transaction value: $10,965
Shares: +1,075
Change %
Price: $10.20
Shares after: 1,075
Date: 02 Oct 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,075
Exercise price: $12.03
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

This option was issued to the reporting person pursuant to the 2024 Equity Incentive Plan for Non-Employee Directors in lieu of retainer fees of $10,964.38